Baseline imbalances and clinical outcomes of atypical antipsychotics in dementia: A meta-epidemiological study of randomized trials
Author:
Affiliation:
1. University Medical Center Groningen, Department of General Practice and Elderly Care Medicine; University of Groningen; Groningen The Netherlands
2. Medicines Evaluation Board; Utrecht The Netherlands
Funder
Dutch Medicines Evaluation Board
Publisher
Wiley
Subject
Psychiatry and Mental health
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/mpr.1757/fullpdf
Reference63 articles.
1. Double blind study of tiapride versus haloperidol and placebo in agitation and aggressiveness in elderly patients with cognitive impairment;Allain;Psychopharmacology,2000
2. Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: Randomised double blind placebo controlled trial;Ballard;BMJ,2005
3. Atypical antipsychotics for aggression and psychosis in Alzheimer's disease (Review);Ballard;The Cochrane Library,2006
4. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia;Brodaty;The Journal of Clinical Psychiatry,2003
5. A systematic review of the efficacy and safety of atypical antipsychotics in patients with psychological and behavioral symptoms of dementia;Carson;Journal of the American Geriatrics Society,2006
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Quantitative assessment of baseline imbalances in evolocumab and alirocumab trials: a meta-epidemiological study;BMC Medical Research Methodology;2024-06-22
2. Accuracy and precision of fixed and random effects in meta‐analyses of randomized control trials for continuous outcomes;Research Synthesis Methods;2023-09-26
3. Baseline imbalance and heterogeneity are present in meta-analyses of randomized clinical trials examining the effects of exercise and medicines for blood pressure management;Hypertension Research;2022-07-26
4. Recent Updates in the Alzheimer’s Disease Etiopathology and Possible Treatment Approaches: A Narrative Review of Current Clinical Trials;Current Molecular Pharmacology;2020-11-02
5. Large Sample Size Fallacy in Trials About Antipsychotics for Neuropsychiatric Symptoms in Dementia;Frontiers in Pharmacology;2020-02-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3